PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC)

Clinical trials for PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC) explained in plain language.

Never miss a new study

Get alerted when new PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC) trials appear

Sign up with your email to follow new studies for PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Major cancer study aims to standardize test results across china

Knowledge-focused Not yet recruiting

This study aims to see if different labs and pathologists get the same results when testing cancer tissue for the HER2 protein. Researchers will look back at tissue samples from about 2,100 Chinese patients with lung, gynecologic, bile duct, or bladder cancer. The goal is to unde…

Matched conditions: PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC)

Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated Mar 11, 2026 14:53 UTC

PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC)

Get alerted when new PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC) trials appear

Major cancer study aims to standardize test results across china